Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticosteroid-induced osteoporosis.

J D Adachi1

  • 1Department of Rheumatology, St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada.

International Journal of Fertility and Women'S Medicine
|September 21, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterizing types and circumstances of fractures in the Canadian Multicentre Osteoporosis Study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2025
Same author

Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group.

Archives of osteoporosis·2022
Same author

Incremental costs of fragility fractures: a population-based matched -cohort study from Ontario, Canada.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Fragility of results from randomized controlled trials supporting the guidelines for the treatment of osteoporosis: a retrospective analysis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Exploring changes in bone mass in individuals with a chronic spinal cord injury.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

A scorecard for osteoporosis in Canada and seven Canadian provinces.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same journal

The paradox of obstetric "near misses": converting maternal mortality into morbidity.

International journal of fertility and women's medicine·2008
Same journal

Fibroid volume, location and symptoms in women undergoing uterine artery embolization: does size or position matter?

International journal of fertility and women's medicine·2008
Same journal

Umbilical cord rupture: a case report and review of literature.

International journal of fertility and women's medicine·2008
Same journal

A continuum of care model for postpartum hemorrhage.

International journal of fertility and women's medicine·2008
Same journal

Climacteric symptom control after the addition of low-dose esterified conjugated estrogens to raloxifene standard doses.

International journal of fertility and women's medicine·2008
Same journal

Value of fetal echocardiography in diagnosis of congenital heart disease in a Serbian university hospital.

International journal of fertility and women's medicine·2008
See all related articles

Corticosteroids cause significant bone loss and fractures in most patients. However, treatments now exist to prevent and even reverse this bone loss, reducing fracture risk.

Area of Science:

  • Endocrinology
  • Rheumatology
  • Osteoporosis Research

Background:

  • Corticosteroids are widely used for various inflammatory and autoimmune conditions.
  • Long-term corticosteroid use is associated with significant bone loss and increased fracture risk.
  • Osteoporosis is a common complication, affecting 30-50% of patients on long-term therapy.

Purpose of the Study:

  • To review the established link between corticosteroid use and bone loss.
  • To highlight the efficacy of current treatments in preventing and managing corticosteroid-induced osteoporosis.
  • To emphasize the importance of clinical awareness regarding fracture risk, especially in postmenopausal women.

Main Methods:

  • Review of historical observations and clinical acceptance of corticosteroid-induced bone loss.

Related Experiment Videos

  • Summary of randomized controlled trials demonstrating the effectiveness of osteoporosis treatments.
  • Emphasis on clinical implications and risk stratification.

    • Main Results:

    • Supraphysiologic corticosteroid doses are a primary cause of clinically significant bone loss.
    • Fractures, particularly at the spine and hip, are common in patients on long-term corticosteroids.
    • Effective treatments are available that preserve or increase bone mass and reduce fracture risk.

    Conclusions:

    • Corticosteroid-induced osteoporosis is a preventable condition.
    • Appropriate drug treatments can significantly mitigate bone loss and fracture risk.
    • Clinicians must recognize the high risk of vertebral fractures, especially in postmenopausal women using corticosteroids.